Cargando…
Taurolidine reduces the tumor stimulating cytokine interleukin-1beta in patients with resectable gastrointestinal cancer: a multicentre prospective randomized trial
BACKGROUND: The effect of additional treatment strategies with antineoplastic agents on intraperitoneal tumor stimulating interleukin levels are unclear. Taurolidine and Povidone-iodine have been mainly used for abdominal lavage in Germany and Europe. METHODS: In the settings of a multicentre (three...
Autores principales: | Braumann, Chris, Gutt, Carsten N, Scheele, Johannes, Menenakos, Charalambos, Willems, Wilhelm, Mueller, Joachim M, Jacobi, Christoph A |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2667516/ https://www.ncbi.nlm.nih.gov/pubmed/19309495 http://dx.doi.org/10.1186/1477-7819-7-32 |
Ejemplares similares
-
Prevention of disease progression in a patient with a gastric cancer-re-recurrence. Outcome after intravenous treatment with the novel antineoplastic agent taurolidine. Report of a case
por: Braumann, Chris, et al.
Publicado: (2006) -
Retroperitoneal Castleman's tumor and paraneoplastic pemphigus: report of a case and review of the literature
por: Menenakos, Charalambos, et al.
Publicado: (2007) -
Taurolidine cooperates with antineoplastic drugs in neuroblastoma cells
por: Eschenburg, Georg, et al.
Publicado: (2014) -
Abstract: Suture Materials Containing the Antimicrobial Taurolidine
por: Lorenc, Z. Paul, et al.
Publicado: (2016) -
Pharmacokinetic study and evaluation of the safety of taurolidine for dogs with osteosarcoma
por: Marley, Kevin, et al.
Publicado: (2013)